Trials / Conditions / Medullary Thyroid Cancer (MTC)
Medullary Thyroid Cancer (MTC)
5 registered clinical trials studyying Medullary Thyroid Cancer (MTC) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer NCT07142005 | M.D. Anderson Cancer Center | — |
| Not Yet Recruiting | A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic NCT07048964 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Completed | Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer NCT03072160 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Nintedanib(BIBF1120) in Thyroid Cancer NCT01788982 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | QUILT-3.006 for Recurrent Medullary Thyroid Cancer NCT01856920 | NantCell, Inc. | Phase 2 |